Aprogen Biologics Inc. (KRX:003060)
South Korea flag South Korea · Delayed Price · Currency is KRW
804.00
+4.00 (0.50%)
At close: Mar 24, 2025, 3:30 PM KST

Aprogen Biologics Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Other Revenue
----0
Upgrade
Revenue
67,37887,36465,19056,48253,320
Upgrade
Revenue Growth (YoY)
-22.88%34.01%15.42%5.93%4.75%
Upgrade
Cost of Revenue
75,22499,33739,38031,60730,515
Upgrade
Gross Profit
-7,846-11,97425,81024,87522,805
Upgrade
Selling, General & Admin
26,34329,78928,91425,94723,579
Upgrade
Research & Development
18,03515,0002,1871,735697.7
Upgrade
Other Operating Expenses
383.38357.6365.27416.95592.21
Upgrade
Operating Expenses
50,73058,71630,01528,85023,885
Upgrade
Operating Income
-58,577-70,690-4,204-3,975-1,081
Upgrade
Interest Expense
-5,514-3,668-274.41-31.14-49.06
Upgrade
Interest & Investment Income
4,2424,48816,64513,5879,176
Upgrade
Earnings From Equity Investments
19,01879,78694.73352.21,510
Upgrade
Currency Exchange Gain (Loss)
-20.53-6.2233.1612.72-26.11
Upgrade
Other Non Operating Income (Expenses)
-10,015564.26209.78347.85423.69
Upgrade
EBT Excluding Unusual Items
-50,86510,47412,50410,2949,953
Upgrade
Gain (Loss) on Sale of Investments
-57,99929,9502,6381,6236,341
Upgrade
Gain (Loss) on Sale of Assets
16.15-151,5373.153.08593.48
Upgrade
Asset Writedown
-154.08-2,271-264.15-2,134-241.5
Upgrade
Other Unusual Items
4,023--1.04-4.76-2.67
Upgrade
Pretax Income
-104,980-113,38314,8819,83116,644
Upgrade
Income Tax Expense
-1,9471,260679.69-2,274
Upgrade
Earnings From Continuing Operations
-104,980-115,33013,6219,15118,918
Upgrade
Minority Interest in Earnings
0.72-2,940-981.32-1,048-7,665
Upgrade
Net Income
-104,979-118,27012,6398,10311,253
Upgrade
Net Income to Common
-104,979-118,27012,6398,10311,253
Upgrade
Net Income Growth
--55.99%-27.99%-
Upgrade
Shares Outstanding (Basic)
12663404032
Upgrade
Shares Outstanding (Diluted)
12663404032
Upgrade
Shares Change (YoY)
99.32%56.05%1.42%25.52%94.17%
Upgrade
EPS (Basic)
-835.00-1875.00312.69203.29354.38
Upgrade
EPS (Diluted)
-835.00-1875.00310.00200.00350.00
Upgrade
EPS Growth
--55.00%-42.86%-
Upgrade
Free Cash Flow
-46,261-61,73924,444-7,0237,112
Upgrade
Free Cash Flow Per Share
-367.96-978.78604.74-176.20223.97
Upgrade
Gross Margin
-11.64%-13.71%39.59%44.04%42.77%
Upgrade
Operating Margin
-86.94%-80.92%-6.45%-7.04%-2.03%
Upgrade
Profit Margin
-155.81%-135.38%19.39%14.34%21.10%
Upgrade
Free Cash Flow Margin
-68.66%-70.67%37.50%-12.43%13.34%
Upgrade
EBITDA
-39,486-49,292-1,800-1,903851.33
Upgrade
EBITDA Margin
-58.60%-56.42%-2.76%-3.37%1.60%
Upgrade
D&A For EBITDA
19,09021,3982,4042,0721,932
Upgrade
EBIT
-58,577-70,690-4,204-3,975-1,081
Upgrade
EBIT Margin
-86.94%-80.92%-6.45%-7.04%-2.03%
Upgrade
Effective Tax Rate
--8.47%6.91%-
Upgrade
Advertising Expenses
521.48736.691,3717,8004,343
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.